Share

October 06, 2020; 95 (14) Correction

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients

First published September 16, 2020, DOI: https://doi.org/10.1212/WNL.0000000000008927
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
138

Share

See original article:

In the article “Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients” by Plavina et al.,1 there is an error in the “Monocyte/VCAM-1 binding” key of figure 3. “Natalizumab continued” should have been represented by a green line and gray square; “Natalizumab interrupted” should have been represented by a red line and black circle. The editorial office regrets the errors.

Figure 3
Figure 3 Functional activity of CD3+ T cells, CD19+ B cells, and monocytes from RESTORE patients

Reference

  1. 1.↵
    1. Plavina T,
    2. Muralidharan KK,
    3. Kuesters G, et al
    . Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients. Neurology 2017;89:1584–1593.
    OpenUrlAbstract/FREE Full Text

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me